The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
WT1 Mutants Reveal SRPK1 to Be a Downstream Angiogenesis Target by Altering VEGF Splicing
Open accessAbstract
Summary Angiogenesis is regulated by the balance of pro-angiogenic VEGF165 and anti-angiogenic VEGF165b splice isoforms. Mutations in WT1, the Wilms’ tumour suppressor gene, suppress VEGF165b and cause abnormal gonadogenesis, renal failure and Wilms’ tumours. In WT1 mutant cells, reduced VEGF165b was due to lack of WT1 mediated transcriptional repression of the splicing factor kinase SRPK1. WT1 bound to the SRPK1 promoter, and repressed expression through a specific WT1 binding-site. In WT1 mutant cells SRPK1-mediated hyperphosphorylation of the oncogenic RNA binding protein SRSF1 regulated splicing of VEGF, and rendered WT1 mutant cells pro-angiogenic. Altered VEGF splicing was reversed by wildtype WT1, knockdown of SRSF1 or SRPK1 and inhibition of SRPK1, which prevented in vitro and in vivo angiogenesis and associated tumour growth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
Houck, K. A., Ferrara, N., Winer, J., Cachianes, G., Li, B., & Leung, D. W. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-12-1806 · Cited by 1,365
The gene encoding the splicing factor SF2/ASF is a proto-oncogene
Karni, R., de Stanchina, E., Lowe, S. W., Sinha, R., Mu, D., & Krainer, A. R. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1209 · Cited by 934
Alternative splicing and genomic structure of the Wilms tumor gene WT1.
Haber, D. A., Sohn, R. L., Buckler, A. J., Pelletier, J., Call, K. M., & Housman, D. E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.21.9618 · Cited by 620
(2002) · PubMed · Cited by 550
VEGF-A splicing: the key to anti-angiogenic therapeutics?
Harper, S. J., & Bates, D. O. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2505 · Cited by 514
Self-citationVEGF165b, an Inhibitory Vascular Endothelial Growth Factor Splice Variant
Woolard, J., Wang, W.-Y., Bevan, H. S., Qiu, Y., Morbidelli, L., Pritchard-Jones, R. O., Cui, T.-G., Sugiono, M., Waine, E., Perrin, R., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0934 · Cited by 451
Self-citationThe many facets of the Wilms' tumour gene, WT1
Hohenstein, P., & Hastie, N. D. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl196 · Cited by 348
Nowak, D. G., Woolard, J., Amin, E. M., Konopatskaya, O., Saleem, M. A., Churchill, A. J., Ladomery, M. R., Harper, S. J., & Bates, D. O. (2008) · Journal of Cell Science · doi:10.1242/jcs.016410 · Cited by 339
Self-citationDavies, R. C., Calvio, C., Bratt, E., Larsson, S. H., Lamond, A. I., & Hastie, N. D. (1998) · Genes & Development · doi:10.1101/gad.12.20.3217 · Cited by 246
Utilization of host SR protein kinases and RNA-splicing machinery during viral replication
Fukuhara, T., Hosoya, T., Shimizu, S., Sumi, K., Oshiro, T., Yoshinaka, Y., Suzuki, M., Yamamoto, N., Herzenberg, L. A., Herzenberg, L. A., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604616103 · Cited by 231
Self-citationZhong, X.-Y., Ding, J.-H., Adams, J. A., Ghosh, G., & Fu, X.-D. (2009) · Genes & Development · doi:10.1101/gad.1752109 · Cited by 229
Varey, A. H. R., Rennel, E. S., Qiu, Y., Bevan, H. S., Perrin, R. M., Raffy, S., Dixon, A. R., Paraskeva, C., Zaccheo, O., Hassan, A. B., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604308 · Cited by 226
Self-citationNowak, D. G., Amin, E. M., Rennel, E. S., Hoareau-Aveilla, C., Gammons, M., Damodoran, G., Hagiwara, M., Harper, S. J., Woolard, J., Ladomery, M. R., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.074930 · Cited by 226
Self-citationRegulation of Human p53 Activity and Cell Localization by Alternative Splicing
Ghosh, A., Stewart, D., & Matlashewski, G. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.18.7987-7997.2004 · Cited by 221
Perrin, R. M., Konopatskaya, O., Qiu, Y., Harper, S., Bates, D. O., & Churchill, A. J. (2005) · Diabetologia · doi:10.1007/s00125-005-1951-8 · Cited by 217
Self-citationNeuropilin-1 promotes VEGFR-2 trafficking through Rab11 vesicles thereby specifying signal output
Ballmer-Hofer, K., Andersson, A. E., Ratcliffe, L. E., & Berger, P. (2011) · Blood · doi:10.1182/blood-2011-01-328773 · Cited by 202
Cébe Suarez, S., Pieren, M., Cariolato, L., Arn, S., Hoffmann, U., Bogucki, A., Manlius, C., Wood, J., & Ballmer-Hofer, K. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6254-9 · Cited by 198
Manetti, M., Guiducci, S., Romano, E., Ceccarelli, C., Bellando-Randone, S., Conforti, M. L., Ibba-Manneschi, L., & Matucci-Cerinic, M. (2011) · Circulation Research · doi:10.1161/circresaha.111.242057 · Cited by 178
RBM5/Luca-15/H37 Regulates Fas Alternative Splice Site Pairing after Exon Definition
Bonnal, S., Martínez, C., Förch, P., Bachi, A., Wilm, M., & Valcárcel, J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.08.008 · Cited by 176
Molecular Diversity of VEGF-A as a Regulator of Its Biological Activity
Woolard, J., Bevan, H. S., Harper, S. J., & Bates, D. O. (2009) · Microcirculation · doi:10.1080/10739680902997333 · Cited by 176
Self-citationHayes, G. M., Carrigan, P. E., & Miller, L. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2969 · Cited by 171
Kawamura, H., Li, X., Harper, S. J., Bates, D. O., & Claesson-Welsh, L. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6577 · Cited by 156
Self-citationThe endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice
Rennel, E. S., Waine, E., Guan, H., Schüler, Y., Leenders, W. P. J., Woolard, J., Sugiono, M., Gillatt, D. A., Kleinerman, E. S., Bates, D. O., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604309 · Cited by 131
Self-citationIdentification of Nuclear and Cytoplasmic mRNA Targets for the Shuttling Protein SF2/ASF
Sanford, J. R., Coutinho, P., Hackett, J. A., Wang, X., Ranahan, W. P., & Cáceres, J. F. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003369 · Cited by 117
Gonçalves, V., Matos, P., & Jordan, P. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp317 · Cited by 116
Yea, S., Narla, G., Zhao, X. Y., Garg, R., Kremer-Tal, S., Hod, E. A., Villanueva, A., Loke, J. C., Tarocchi, M., Akita, K., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.015 · Cited by 106
Merdzhanova, G., Gout, S., Kéramidas, M., Edmond, V., Coll, J., Brambilla, C., Brambilla, E. M., Gazzéri, S., & Eymin, B. (2010) · Oncogene · doi:10.1038/onc.2010.281 · Cited by 99
The post-transcriptional roles of WT1, a multifunctional zinc-finger protein
Morrison, A. A., Viney, R. L., & Ladomery, M. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.10.002 · Cited by 93
Self-citationBor, Y.-C., Swartz, J. E., Morrison, A. A., Rekosh, D. M., Ladomery, M., & Hammarskjöld, M. (2006) · Genes & Development · doi:10.1101/gad.1402306 · Cited by 90
Self-citationImpaired Glomerular Maturation and Lack of VEGF165b in Denys-Drash Syndrome
Schumacher, V., Jeruschke, S., Eitner, F., Becker, J. U., Pitschke, G., Ince, Y., Miner, J. H., Leuschner, I., Engers, R., Everding, A. S., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006020124 · Cited by 74
Self-citationRecombinant Human VEGF 165 b Inhibits Experimental Choroidal Neovascularization
Hua, J., Spee, C. K., Kase, S., Rennel, E., Magnussen, A., Qiu, Y., Varey, A. H. R., Dhayade, S., Churchill, A., Harper, S. J., et al. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4360 · Cited by 69
Self-citationNatoli, T. A., Liu, J., Eremina, V., Hodgens, K. J., Li, C., Hamano, Y., Mundel, P. H., Kalluri, R., Miner, J. H., Quaggin, S. E., et al. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000022420.48110.4b · Cited by 69
Multiple roles for the Wilms' tumor suppressor, WT1.
Davies, R. C., Moore, A. W., Schedl, A., Bratt, E., Miyahawa, K., Ladomery, M., Miles, C. G., Menke, A. L., van Heyningen, V., & Hastie, N. D. (1999) · PubMed · Cited by 59
Self-citationQiu, Y., Bevan, H. S., Weeraperuma, S., Wratting, D., Murphy, D., Neal, C. R., Bates, D. O., & Harper, S. J. (2007) · The FASEB Journal · doi:10.1096/fj.07-9718com · Cited by 59
Self-citationDíaz, R., Peña, C., Silva, J., Lorenzo, Y., García‐Barberán, V., García, J. M., Sánchez, A., Lara, P. E., Yuste, R. S., Bonilla, F., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23619 · Cited by 55
ANGIOGENESIS AND ANGIOGENIC GROWTH FACTORS IN WILMS TUMOR
Sköldenberg, E. G., Christiansson, J., Sandstedt, B., Larsson, A. O., Läckgren, G., & Christofferson, R. H. B. (2001) · The Journal of Urology · doi:10.1016/s0022-5347(05)66183-6 · Cited by 49
Rennel, E. S., Varey, A. H. R., Churchill, A. J., Wheatley, E. R., Stewart, L., Mather, S. J., Bates, D. O., & Harper, S. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605249 · Cited by 48
Self-citationSRPK1: A cisplatin sensitive protein expressed in retinoblastoma
Krishnakumar, S., Mohan, A., Kandalam, M., Ramkumar, H. L., Venkatesan, N., & Das, R. R. (2006) · Pediatric Blood & Cancer · doi:10.1002/pbc.21088 · Cited by 46
Artac, R. A., McFee, R. M., Smith, R. A. L., et al. (2009) · Biology of Reproduction · doi:10.1095/biolreprod.109.078097 · Cited by 42
Overexpression of VEGF165b in Podocytes Reduces Glomerular Permeability
Qiu, Y., Ferguson, J., Oltean, S., Neal, C., Kaura, A., Bevan, H. S., Wood, E., Sage, L. M., Lanati, S., Nowak, D. G., et al. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009060617 · Cited by 41
Self-citationViney, R. L., Morrison, A. A., van den Heuvel, L. P., Ni, L., Mathieson, P. W., Saleem, M. A., & Ladomery, M. (2007) · PROTEOMICS · doi:10.1002/pmic.200600666 · Cited by 37
Self-citationVascular Endothelial Growth Factor (VEGF) Is Suppressed in WT1-Transfected LNCaP Cells
Graham, K., Li, W., Williams, B. R. G., & Fraizer, G. C. (2006) · Gene Expression · doi:10.3727/000000006783991953 · Cited by 17
Cited by
Alternative splicing: a pivotal step between eukaryotic transcription and translation
Kornblihtt, A. R., Schor, I. E., Alló, M., Dujardin, G., Petrillo, E., & Muñoz, M. J. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3525 · Cited by 853
Roles and mechanisms of alternative splicing in cancer — implications for care
Bonnal, S. C., López-Oreja, I., & Valcárcel, J. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0350-x · Cited by 731
RNA splicing factors as oncoproteins and tumour suppressors
Dvinge, H., Kim, E., Abdel-Wahab, O., & Bradley, R. K. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.51 · Cited by 687
Hallmarks of alternative splicing in cancer
Oltean, S., & Bates, D. O. (2014) · Oncogene · doi:10.1038/onc.2013.533 · Cited by 664
Self-citationRegulation of splicing by SR proteins and SR protein-specific kinases
Zhou, Z., & Fu, X.-D. (2013) · Chromosoma · doi:10.1007/s00412-013-0407-z · Cited by 478
Metadata
- Authors
- Amin, E. M., Oltean, S., Hua, J., Gammons, M. V. R., Hamdollah-Zadeh, M., Welsh, G. I., Cheung, M.-K., Ni, L., Kase, S., Rennel, E. S., Symonds, K. E., Nowak, D. G., Royer-Pokora, B., Saleem, M. A., Hagiwara, M., Schumacher, V. A., Harper, S. J., Hinton, D. R., Bates, D. O., & Ladomery, M. R.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2011-12
- Volume
- 20
- Issue
- 6
- Pages
- 768-780
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2027701384
- Cited by
- 253
- References
- 43
- FWCI
- 6.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.